Study guide
16.4 HIPAA Confidentiality and Record Release
AMT Certified Medical Laboratory Assistant CMLA
Track your progress as you read
Finished sections get a check mark.
1 Introduction
1.1 Current Exam Facts 1.2 Blueprint Weights and Study Strategy
2 Chapter 2: Safety Terminology and Infection Control
2.1 Safety, Infection, and OSHA Terminology 2.2 Chain of Infection and Precautions 2.3 Isolation, Aseptic Technique, and Disease Prevention
3 Chapter 3: OSHA, HazCom, and Public-Health Reporting
3.1 OSHA Bloodborne Pathogens and Needlestick Safety 3.2 Hazard Communication, SDS, and GHS 3.3 Mandated Safety Rules and Public-Health Reporting
4 Chapter 4: Quality Assessment and Quality Control
4.1 Quality Control and Assessment Terminology 4.2 QC vs QA, Internal vs External QC, and Proficiency Testing 4.3 Daily QC, Temperature Logs, and Corrective Action 4.4 Instrument Maintenance and Calibration in CMLA Scope
5 Chapter 5: Waived-Test Integrity and Confirmatory Testing
5.1 Off-Label Waived Testing and High-Complexity Default 5.2 Following Manufacturer Instructions for Waived Tests 5.3 Confirmatory and Supplemental Testing
6 Chapter 6: Phlebotomy Foundations
6.1 Phlebotomy Terminology and Equipment 6.2 Serum, Plasma, Whole Blood, and Anticoagulation 6.3 Patient Identification and Container Identification
7 Chapter 7: Venipuncture, Order of Draw, and Specimen Integrity
7.1 Patient Preparation and Physiologic Effects 7.2 Vein Selection and Venipuncture Technique 7.3 Order of Draw and Tube Additives 7.4 Short Draws, Hemolysis, and Plasma-on-Cells Limits
8 Chapter 8: Capillary Collection, Processing, and Legal Specimens
8.1 Capillary Puncture Including Infants 8.2 Post-Care, Labeling, Transport, Processing, and Send-Outs 8.3 Specimens Used as Legal Evidence
9 Chapter 9: Non-Blood Collection and Preanalytical Errors
9.1 Urine Collection Types and Patient Instruction 9.2 Urine Suitability, Storage, Preservatives, and Rejection 9.3 Other Specimens and Time/Temperature Requirements 9.4 Shipping, Slide Prep, Preanalytical Errors, and Complications
10 Chapter 10: Clinical Chemistry
10.1 Clinical Chemistry Terminology and Test Families 10.2 Chemistry Instrumentation, Cleaning, and Maintenance 10.3 Point-of-Care and Waived Chemistry Testing 10.4 Toxicology Within CMLA Scope
11 Chapter 11: Hematology and Coagulation
11.1 Hematology Terminology, Blood Functions, and Cell Types 11.2 Hematology Instrumentation, QC, and Calibration 11.3 Coagulation: PT, PTT, INR, Heparin, and Warfarin 11.4 Point-of-Care and Waived Hematology Tests
12 Chapter 12: Immunology, Serology, and Immunohematology
12.1 Antigen-Antibody Principles 12.2 Blood Types, Rh, and Immunohematology Basics 12.3 Waived Immunology, Serology, and Immunohematology Procedures
13 Chapter 13: Microbiology
13.1 Microbiology Terminology and Specimen Appropriateness 13.2 Aseptic Processing, Storage, and Transport of Micro Specimens 13.3 Media, Cultures, and Procedure Matching 13.4 Stains, KOH, Wet Preps, Reagents, and Controls
14 Chapter 14: Urinalysis and Microscopy
14.1 Urinalysis Terminology 14.2 Waived Urinalysis Procedures and Specimen Handling 14.3 Microscopy Parts, Magnification, Wet Prep, and Cleaning
15 Chapter 15: Basic Anatomy and Physiology
15.1 Anatomy Relevant to Laboratory Testing 15.2 Physiology Relevant to Laboratory Testing
16 Chapter 16: Legal, Ethical, and HIPAA Foundations
16.1 Consent, ABN, Test Ordering, and PPM Restrictions 16.2 Patient's Bill of Rights, Refusal, and Medicolegal Risk 16.3 Professional Appearance, Conduct, and Social Media 16.4 HIPAA Confidentiality and Record Release
17 Chapter 17: Clerical Skills, Communication, and Critical Values
17.1 Reports, Abnormal Results, and Critical-Value Notification 17.2 HIT Data, Inventory, Expirations, and Billing/Coding 17.3 Patient Instruction, Communication, Telephone, and Time Management
16.4 HIPAA Confidentiality and Record Release
Key Takeaways Explain This Topic AI
45 CFR § 164.524, cited on AMT CMLA-REF-2025-1, gives individuals a right to inspect and obtain a copy of PHI in a designated record set; the covered entity must act no later than 30 days after receipt, with one written extension of no more than 30 days.
Minimum necessary (45 CFR § 164.502(b)) and need-to-know limit workforce snooping and extra disclosures; the standard does not apply to disclosures to a provider for treatment or to disclosures to the individual.
Release to family, an employer, or police is not automatic because someone asked; follow SOP, a valid HIPAA authorization, personal-representative rules, or a lawful process such as a warrant, court order, or a listed Privacy Rule exception.
Elevator and cafeteria talk, misdirected fax or email, and PHI left on printers are confidentiality failures even when a last name is omitted or the conversation is 'only among staff.'
Do not invent current HIPAA civil-penalty dollar amounts as CMLA facts; contain the disclosure, notify the privacy officer, and follow facility incident procedure.
Last updated: August 2026
AMT IV.11.C is two duties: observe tenets of confidentiality and observe tenets of appropriate record release . The reference list on CMLA-REF-2025-1 cites 45 CFR § 164.524 (2025), Access of individuals to protected health information , retrieved December 18, 2025. That section is the patient's access right. The rest of the Privacy Rule tells you when everyone else may see the chart. CMLA will not ask you to litigate every exception. It will ask whether you gossip, whether you hand a spouse a printout, and whether you know the patient can request their own record.
Quick Answer: Speak about a patient only when the job requires it, and only as much as the job requires ( minimum necessary / need-to-know ). The patient may access PHI under § 164.524 (act within 30 days ; one 30-day written extension). Family, employers, and police need authorization or a lawful process—not curiosity or a badge in the lobby. No elevator talk, no wrong-number fax, no results on the printer.
What counts as PHI and who is covered
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule protects protected health information (PHI) : individually identifiable health information held or transmitted by a covered entity (health plans, most health-care providers who bill electronically, and health-care clearinghouses) or a business associate . Identifiers plus a clinical fact are enough: name, medical record number, full face photo, address, date of service, accession number, and a test result. A tube rack with readable labels is PHI. A whiteboard with last names and "HIV f/u" is PHI.
Confidentiality is the professional duty not to disclose that information except as authorized. HIPAA is the federal floor; state law and facility SOP may be stricter. AMT Standard 4 requires certificants to comply with privacy laws and safeguard confidences unless legally authorized or compelled to disclose.
Minimum necessary and need-to-know
45 CFR § 164.502(b) requires reasonable efforts to limit PHI uses, disclosures, and requests to the minimum necessary to accomplish the purpose. Facilities implement that with role-based access: accessioning sees orders, a reference-lab courier sees a packing list, billing sees codes, and a collector sees the requisition for the patient in front of them. Need-to-know is the workplace translation: you open the record because you are collecting, processing, or reporting that patient, not because a neighbor is on the schedule.
Minimum necessary does not apply to disclosures to or requests by a health-care provider for treatment , uses or disclosures to the individual , or uses or disclosures under a valid authorization (§ 164.508), among other listed exceptions. That is why a covering physician can receive what is needed to treat, and why you do not withhold a patient's own results from a proper access request by citing minimum necessary. It is also why curiosity clicks in the electronic health record remain a firing and reporting event: treatment of your assigned work is not a license to read every celebrity on the census.
45 CFR § 164.524 — patient access to PHI
Section 164.524 is the named CMLA-REF cite. Except for limited exclusions (notably psychotherapy notes and information compiled for a legal proceeding), an individual has a right to inspect and obtain a copy of PHI about that individual in a designated record set (medical and billing records the covered entity uses to make decisions). Laboratories typically hold reportable results and accession records in that set.
Timelines (do not invent others): the covered entity must act on the request no later than 30 days after receipt—either provide access or issue a written denial. If it cannot meet that, it may take one extension of no more than 30 days , and only if it gives the individual a written statement of the delay reason and the completion date within the original 30 days (§ 164.524(b)(2)). HHS guidance treats these as calendar days and calls 30 days an outer limit, not a goal. Provide the form and format requested if readily producible, including electronic copies of electronic records. Reasonable cost-based fees may cover copying labor, supplies, postage, and agreed summaries—not a punitive chart-retrieval penalty you invent.
A CMLA does not freelance denials. Access requests go to the medical records / health information office or privacy official named in policy. If you are handed a patient request at the window, you route it; you do not refuse because "labs are only for the doctor." Limited unreviewable and reviewable denial grounds exist (endangerment determinations by a licensed professional, certain inmate copies, research suspensions with prior agreement). Those are not collector discretion.
Appropriate record release: patient, family, employer, police
Release is a process, not a favor.
Requestor Default CMLA action What makes release appropriate
The patient (or personal representative) Route to the access SOP; do not hide results § 164.524 access; identity verification; facility forms
Family / friend Do not hand over a printout because they drove the patient Valid authorization ; personal representative paperwork; or limited involvement-in-care disclosures the patient has not objected to, per SOP (§ 164.510)
Employer Do not fax a pre-employment or workers' compensation result from the clinical chart on a supervisor's say-so Written authorization or a specific occupational/legal pathway in SOP; workplace drug screens follow the program's custody forms (Chapter 8.3), not hallway requests
Police / law enforcement Do not open the LIS because a uniform is at the desk Warrant, court order, grand-jury subpoena, or a listed § 164.512(f) law-enforcement provision; facility legal/privacy review. Some states add stricter lab-result rules
Another treating provider Use the treatment pathway / LIS routing Treatment exception; still verify identity of the requestor per SOP
Insurer / payer Billing office process Payment operations; minimum necessary for that purpose
A spouse is not automatically a personal representative. A parent of an adult patient is not automatically authorized. A badge is not a HIPAA key. If the situation is a true emergency disclosure, that is a privacy-officer / clinical-leadership call under the applicable exception—not a collector improvising a stack of reports. Follow SOP and legal process is the exam-safe close.
Authorizations (§ 164.508) are specific: who may disclose, to whom, what information, for what purpose, expiration, signature. A sticky note that says "OK to tell my husband" is not a substitute unless policy treats a documented informal permission for a limited involvement-in-care discussion. Results by telephone follow identity-verification SOP (Chapter 17), not a callback to an unverified number on a requisition.
Everyday breaches CMLA actually sees
Elevator, cafeteria, and hallway talk. "The diabetic in bay 2 with the huge viral load" is a disclosure to everyone within earshot, including visitors. Staff-only does not mean public-space-only. Close the door. Use accession numbers on the bench, not shouted names plus tests.
Misdirected fax or email. Wrong cover sheet, wrong stored number, open cc: line, or a result attached to the wrong patient email is a release. Stop, notify the privacy officer, attempt to retrieve or request destruction, and document. Do not ignore it because "they probably deleted it."
PHI on printers, copiers, and screens. Result printers in a hallway, labels facing a waiting room, a signed-on LIS terminal, and a courier manifest left on a counter are access for whoever walks by. Pull printouts immediately, use cover sheets, lock screens, and face labels down in public.
Other classics: taking work home on an unencrypted USB drive, photographing a funny result, discussing a neighbor's pregnancy test with a coworker who is not in the testing chain, and releasing a verbal result to a caller you did not authenticate.
Civil money penalties exist for HIPAA violations, and HHS Office for Civil Rights publishes enforcement figures that change. Do not invent dollar amounts as current official CMLA facts. The exam-useful response is: report, contain, document, cooperate with the privacy officer. Do not hide a mis-fax to avoid trouble.
In practice
A patient's adult child asks for yesterday's metabolic panel "because Mom wants me to keep track." You do not pull the report. You explain that records go through the release-of-information process and offer the access form. A police officer asks whether a named person was in the lab this morning. You do not confirm from memory at the window; you route the officer to the administrator and privacy process. You shred a misprinted label, lock your screen when you walk away, and save the result discussion for a closed work area.
Exam traps
Minimum necessary is not a reason to deny a patient their own § 164.524 access.
Family, employers, and police are different requestors with different rules; none is "always yes."
Thirty days is the access action deadline in the regulation, with one documented 30-day extension—not 90 business days.
Elevator talk with no last name can still be PHI.
Penalty dollar figures you memorized from a blog are not CMLA content.